APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Edaravone Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Edaravone Injection Market Analysis and Forecast 2026-2032

Report ID 173987360220 December 2025198 pages

Choose your research edition.

Industry ResearchEdaravone Injection Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Edaravone Injection Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Edaravone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edaravone Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Edaravone Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Edaravone Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Edaravone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Edaravone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Edaravone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Edaravone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Edaravone Injection include Mitsubishi Tanabe Pharma. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Edaravone Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Edaravone Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Edaravone Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Edaravone Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Edaravone Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Edaravone Injection sales, projected growth trends, production technology, application and end-user industry.

Edaravone Injection Segment by Company

Mitsubishi Tanabe Pharma

Edaravone Injection Segment by Type

20ml

100ml

Edaravone Injection Segment by Application

Hospital

Pharmacy

Edaravone Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edaravone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Edaravone Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Edaravone Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Edaravone Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Edaravone Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 20ml Major Manufacturers Table 3. 100ml Major Manufacturers Table 4. Global Edaravone Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Edaravone Injection Industry Trends Table 8. Edaravone Injection Industry Drivers Table 9. Edaravone Injection Industry Opportunities and Challenges Table 10. Edaravone Injection Industry Restraints Table 11. Global Edaravone Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Edaravone Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Edaravone Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Edaravone Injection Revenue Market Share by Region (2021-2026) Table 15. Global Edaravone Injection Revenue Market Share by Region (2027-2032) Table 16. Global Edaravone Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Edaravone Injection Sales by Region (2021-2026) & (k units) Table 18. Global Edaravone Injection Sales by Region (2027-2032) & (k units) Table 19. Global Edaravone Injection Sales Market Share by Region (2021-2026) Table 20. Global Edaravone Injection Sales Market Share by Region (2027-2032) Table 21. Global Edaravone Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Edaravone Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Edaravone Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Edaravone Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Edaravone Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Edaravone Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Edaravone Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Edaravone Injection Manufacturers, Product Type & Application Table 29. Global Edaravone Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Edaravone Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Edaravone Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Edaravone Injection Revenue Market Share by Type (2021-2026) Table 36. Global Edaravone Injection Revenue Market Share by Type (2027-2032) Table 37. Global Edaravone Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Edaravone Injection Sales by Type (2021-2026) & (k units) Table 39. Global Edaravone Injection Sales by Type (2027-2032) & (k units) Table 40. Global Edaravone Injection Sales Market Share by Type (2021-2026) Table 41. Global Edaravone Injection Sales Market Share by Type (2027-2032) Table 42. Global Edaravone Injection Price by Type (2021-2026) & (US$/unit) Table 43. Global Edaravone Injection Price by Type (2027-2032) & (US$/unit) Table 44. Global Edaravone Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Edaravone Injection Revenue Market Share by Application (2021-2026) Table 48. Global Edaravone Injection Revenue Market Share by Application (2027-2032) Table 49. Global Edaravone Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Edaravone Injection Sales by Application (2021-2026) & (k units) Table 51. Global Edaravone Injection Sales by Application (2027-2032) & (k units) Table 52. Global Edaravone Injection Sales Market Share by Application (2021-2026) Table 53. Global Edaravone Injection Sales Market Share by Application (2027-2032) Table 54. Global Edaravone Injection Price by Application (2021-2026) & (US$/unit) Table 55. Global Edaravone Injection Price by Application (2027-2032) & (US$/unit) Table 56. Mitsubishi Tanabe Pharma Company Information Table 57. Mitsubishi Tanabe Pharma Business Overview Table 58. Mitsubishi Tanabe Pharma Edaravone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolio Table 60. Mitsubishi Tanabe Pharma Recent Development Table 61. North America Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Edaravone Injection Sales by Type (2021-2026) & (k units) Table 64. North America Edaravone Injection Sales by Type (2027-2032) & (k units) Table 65. North America Edaravone Injection Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Edaravone Injection Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Edaravone Injection Sales by Application (2021-2026) & (k units) Table 70. North America Edaravone Injection Sales by Application (2027-2032) & (k units) Table 71. North America Edaravone Injection Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Edaravone Injection Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Edaravone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Edaravone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Edaravone Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America Edaravone Injection Sales by Country (2021-2026) & (k units) Table 78. North America Edaravone Injection Sales by Country (2027-2032) & (k units) Table 79. North America Edaravone Injection Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Edaravone Injection Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 82. Canada Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 83. Mexico Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 84. Europe Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Edaravone Injection Sales by Type (2021-2026) & (k units) Table 87. Europe Edaravone Injection Sales by Type (2027-2032) & (k units) Table 88. Europe Edaravone Injection Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Edaravone Injection Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Edaravone Injection Sales by Application (2021-2026) & (k units) Table 93. Europe Edaravone Injection Sales by Application (2027-2032) & (k units) Table 94. Europe Edaravone Injection Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Edaravone Injection Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Edaravone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Edaravone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Edaravone Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe Edaravone Injection Sales by Country (2021-2026) & (k units) Table 101. Europe Edaravone Injection Sales by Country (2027-2032) & (k units) Table 102. Europe Edaravone Injection Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Edaravone Injection Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 105. France Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 106. U.K. Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 107. Italy Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 108. Russia Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 109. Spain Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 112. Sweden Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 113. Poland Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 114. China Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 115. China Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 116. China Edaravone Injection Sales by Type (2021-2026) & (k units) Table 117. China Edaravone Injection Sales by Type (2027-2032) & (k units) Table 118. China Edaravone Injection Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Edaravone Injection Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 121. China Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 122. China Edaravone Injection Sales by Application (2021-2026) & (k units) Table 123. China Edaravone Injection Sales by Application (2027-2032) & (k units) Table 124. China Edaravone Injection Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Edaravone Injection Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Edaravone Injection Sales by Type (2021-2026) & (k units) Table 129. Asia Edaravone Injection Sales by Type (2027-2032) & (k units) Table 130. Asia Edaravone Injection Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Edaravone Injection Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Edaravone Injection Sales by Application (2021-2026) & (k units) Table 135. Asia Edaravone Injection Sales by Application (2027-2032) & (k units) Table 136. Asia Edaravone Injection Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Edaravone Injection Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Edaravone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Edaravone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Edaravone Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia Edaravone Injection Sales by Country (2021-2026) & (k units) Table 143. Asia Edaravone Injection Sales by Country (2027-2032) & (k units) Table 144. Asia Edaravone Injection Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Edaravone Injection Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 147. South Korea Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 148. India Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 149. Australia Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Edaravone Injection Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Edaravone Injection Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Edaravone Injection Sales by Type (2021-2026) & (k units) Table 155. SAMEA Edaravone Injection Sales by Type (2027-2032) & (k units) Table 156. SAMEA Edaravone Injection Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Edaravone Injection Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Edaravone Injection Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Edaravone Injection Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Edaravone Injection Sales by Application (2021-2026) & (k units) Table 161. SAMEA Edaravone Injection Sales by Application (2027-2032) & (k units) Table 162. SAMEA Edaravone Injection Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Edaravone Injection Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Edaravone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Edaravone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Edaravone Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA Edaravone Injection Sales by Country (2021-2026) & (k units) Table 169. SAMEA Edaravone Injection Sales by Country (2027-2032) & (k units) Table 170. SAMEA Edaravone Injection Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Edaravone Injection Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 173. Argentina Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 174. Chile Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 175. Colombia Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 176. Peru Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 178. Israel Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 179. UAE Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 180. Turkey Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 181. Iran Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 182. Egypt Edaravone Injection Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Edaravone Injection Distributors List Table 186. Edaravone Injection Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Edaravone Injection Image Figure 2. Global Edaravone Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edaravone Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 20ml Image Figure 5. 100ml Image Figure 6. Global Edaravone Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Edaravone Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Edaravone Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Edaravone Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Edaravone Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Edaravone Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Edaravone Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Edaravone Injection Sales (2021-2032) & (k units) Figure 16. Global Edaravone Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Edaravone Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Edaravone Injection Sales YoY (2021-2032) & (k units) Figure 19. Europe Edaravone Injection Sales YoY (2021-2032) & (k units) Figure 20. China Edaravone Injection Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Edaravone Injection Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Edaravone Injection Sales YoY (2021-2032) & (k units) Figure 23. Global Edaravone Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Edaravone Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Edaravone Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Edaravone Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Edaravone Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Edaravone Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Edaravone Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Edaravone Injection Sales Market Share by Type (2021-2032) Figure 32. Global Edaravone Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Edaravone Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Edaravone Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Edaravone Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Edaravone Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Edaravone Injection Sales Market Share by Application (2021-2032) Figure 38. North America Edaravone Injection Revenue Share by Type (2021-2032) Figure 39. North America Edaravone Injection Sales Share by Type (2021-2032) Figure 40. North America Edaravone Injection Revenue Share by Application (2021-2032) Figure 41. North America Edaravone Injection Sales Share by Application (2021-2032) Figure 42. North America Edaravone Injection Revenue Share by Country (2021-2032) Figure 43. North America Edaravone Injection Sales Share by Country (2021-2032) Figure 44. Europe Edaravone Injection Revenue Share by Type (2021-2032) Figure 45. Europe Edaravone Injection Sales Share by Type (2021-2032) Figure 46. Europe Edaravone Injection Revenue Share by Application (2021-2032) Figure 47. Europe Edaravone Injection Sales Share by Application (2021-2032) Figure 48. Europe Edaravone Injection Revenue Share by Country (2021-2032) Figure 49. Europe Edaravone Injection Sales Share by Country (2021-2032) Figure 50. China Edaravone Injection Revenue Share by Type (2021-2032) Figure 51. China Edaravone Injection Sales Share by Type (2021-2032) Figure 52. China Edaravone Injection Revenue Share by Application (2021-2032) Figure 53. China Edaravone Injection Sales Share by Application (2021-2032) Figure 54. Asia Edaravone Injection Revenue Share by Type (2021-2032) Figure 55. Asia Edaravone Injection Sales Share by Type (2021-2032) Figure 56. Asia Edaravone Injection Revenue Share by Application (2021-2032) Figure 57. Asia Edaravone Injection Sales Share by Application (2021-2032) Figure 58. Asia Edaravone Injection Revenue Share by Country (2021-2032) Figure 59. Asia Edaravone Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Edaravone Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Edaravone Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Edaravone Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Edaravone Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Edaravone Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Edaravone Injection Sales Share by Country (2021-2032) Figure 66. Edaravone Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Edaravone Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 20ml
  • 100ml
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Mitsubishi Tanabe Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Edaravone Injection Market by Type
  3. 1.2.1 Global Edaravone Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 20ml
  5. 1.2.3 100ml
  6. 1.3 Edaravone Injection Market by Application
  7. 1.3.1 Global Edaravone Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Edaravone Injection Market Dynamics
  1. 2.1 Edaravone Injection Industry Trends
  2. 2.2 Edaravone Injection Industry Drivers
  3. 2.3 Edaravone Injection Industry Opportunities and Challenges
  4. 2.4 Edaravone Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Edaravone Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Edaravone Injection Revenue by Region
  3. 3.2.1 Global Edaravone Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Edaravone Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Edaravone Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Edaravone Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Edaravone Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Edaravone Injection Sales by Region
  9. 3.4.1 Global Edaravone Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Edaravone Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Edaravone Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Edaravone Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Edaravone Injection Revenue by Manufacturers
  2. 4.1.1 Global Edaravone Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Edaravone Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Edaravone Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Edaravone Injection Sales by Manufacturers
  6. 4.2.1 Global Edaravone Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Edaravone Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Edaravone Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Edaravone Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Edaravone Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Edaravone Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Edaravone Injection Manufacturers, Product Type & Application
  13. 4.7 Global Edaravone Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Edaravone Injection Market CR5 and HHI
  16. 4.8.2 2025 Edaravone Injection Tier 1, Tier 2, and Tier 3
5 Edaravone Injection Market by Type
  1. 5.1 Global Edaravone Injection Revenue by Type
  2. 5.1.1 Global Edaravone Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Edaravone Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Edaravone Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Edaravone Injection Sales by Type
  6. 5.2.1 Global Edaravone Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edaravone Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Edaravone Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Edaravone Injection Price by Type
6 Edaravone Injection Market by Application
  1. 6.1 Global Edaravone Injection Revenue by Application
  2. 6.1.1 Global Edaravone Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Edaravone Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Edaravone Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Edaravone Injection Sales by Application
  6. 6.2.1 Global Edaravone Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Edaravone Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Edaravone Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Edaravone Injection Price by Application
7 Company Profiles
  1. 7.1 Mitsubishi Tanabe Pharma
  2. 7.1.1 Mitsubishi Tanabe Pharma Company Information
  3. 7.1.2 Mitsubishi Tanabe Pharma Business Overview
  4. 7.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolio
  6. 7.1.5 Mitsubishi Tanabe Pharma Recent Developments
8 North America
  1. 8.1 North America Edaravone Injection Market Size by Type
  2. 8.1.1 North America Edaravone Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Edaravone Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Edaravone Injection Price by Type (2021-2032)
  5. 8.2 North America Edaravone Injection Market Size by Application
  6. 8.2.1 North America Edaravone Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Edaravone Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Edaravone Injection Price by Application (2021-2032)
  9. 8.3 North America Edaravone Injection Market Size by Country
  10. 8.3.1 North America Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Edaravone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Edaravone Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Edaravone Injection Market Size by Type
  2. 9.1.1 Europe Edaravone Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Edaravone Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Edaravone Injection Price by Type (2021-2032)
  5. 9.2 Europe Edaravone Injection Market Size by Application
  6. 9.2.1 Europe Edaravone Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Edaravone Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Edaravone Injection Price by Application (2021-2032)
  9. 9.3 Europe Edaravone Injection Market Size by Country
  10. 9.3.1 Europe Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Edaravone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Edaravone Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Edaravone Injection Market Size by Type
  2. 10.1.1 China Edaravone Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Edaravone Injection Sales by Type (2021-2032)
  4. 10.1.3 China Edaravone Injection Price by Type (2021-2032)
  5. 10.2 China Edaravone Injection Market Size by Application
  6. 10.2.1 China Edaravone Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Edaravone Injection Sales by Application (2021-2032)
  8. 10.2.3 China Edaravone Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Edaravone Injection Market Size by Type
  2. 11.1.1 Asia Edaravone Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Edaravone Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Edaravone Injection Price by Type (2021-2032)
  5. 11.2 Asia Edaravone Injection Market Size by Application
  6. 11.2.1 Asia Edaravone Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Edaravone Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Edaravone Injection Price by Application (2021-2032)
  9. 11.3 Asia Edaravone Injection Market Size by Country
  10. 11.3.1 Asia Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Edaravone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Edaravone Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Edaravone Injection Market Size by Type
  2. 12.1.1 SAMEA Edaravone Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Edaravone Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Edaravone Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Edaravone Injection Market Size by Application
  6. 12.2.1 SAMEA Edaravone Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Edaravone Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Edaravone Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Edaravone Injection Market Size by Country
  10. 12.3.1 SAMEA Edaravone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Edaravone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Edaravone Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Edaravone Injection Value Chain Analysis
  2. 13.1.1 Edaravone Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Edaravone Injection Production Mode & Process
  6. 13.2 Edaravone Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Edaravone Injection Distributors
  9. 13.2.3 Edaravone Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst